Article
Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology - 1 Mar 1997
Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt D S, Genest J, Rozen R
Abstract excerpt
Mild hyperhomocysteinemia, a risk factor for occlusive arterial disease, can be caused by disruptions of homocysteine metabolism. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the synthesis of 5-methyltetrahydrofolate, the methyl donor for homocysteine remethylation to methionine. A common mutation in MTHFR, an alanine-to-valine substitution, may contribute to mild hyperhomocysteinemia in coronary artery...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
